Literature DB >> 10699887

Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists.

R J Schlemper1, S M Dawsey, M Itabashi, A Iwashita, Y Kato, M Koike, K J Lewin, R H Riddell, T Shimoda, P Sipponen, M Stolte, H Watanabe.   

Abstract

BACKGROUND: Large discrepancies have been found between Western and Japanese pathologists in the diagnosis of adenoma/dysplasia versus carcinoma for gastric and colorectal glandular lesions. It is important to determine whether similar differences exist in the diagnosis of esophageal squamous lesions.
METHODS: Eleven expert gastrointestinal pathologists from Japan, North America, and Europe individually reviewed a set of microscopic slides containing 21 sections of biopsies and corresponding endoscopic mucosal resection specimens from Japanese patients with superficial esophageal squamous neoplastic lesions. The pathologists indicated the pathologic findings on which they based each diagnosis.
RESULTS: Invasion was the most important diagnostic criterion of carcinoma for the Western pathologists whereas nuclear and structural features were more important for the Japanese pathologists. For two sections showing low grade dysplasia according to most Western pathologists, the Japanese pathologists diagnosed suspected carcinoma in one case and definite carcinoma in the other. For nine sections with high grade dysplasia according to the Western pathologists, the Japanese pathologists diagnosed suspected carcinoma in two cases and definite carcinoma in seven cases. For six sections with suspected carcinoma according to most Western pathologists, the Japanese pathologists diagnosed suspected carcinoma in one case and definite carcinoma in five cases. Four sections showed definite carcinoma according to both the Western and Japanese pathologists. Thus, there was agreement among the Western and Japanese pathologists for only 5 of the 21 sections (kappa value, 0.04). However, when high grade dysplasia, noninvasive carcinoma, and suspected carcinoma were grouped together, the agreement was excellent (19 of the 21 sections; kappa value, 0.75).
CONCLUSIONS: In Japan, esophageal squamous cell carcinoma is diagnosed mainly based on nuclear criteria, even in cases judged to be noninvasive low grade dysplasia in the West. This difference in diagnostic practice may contribute to the relatively high incidence rate and good prognosis of superficial esophageal carcinoma in Japan. To improve the comparability of research data, the authors recommend that high grade dysplasia, noninvasive carcinoma, and suspected carcinoma be grouped together into one category of "noninvasive high grade neoplasia." [See editorial on pages 969-70, this issue.] Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Year:  2000        PMID: 10699887     DOI: 10.1002/(sici)1097-0142(20000301)88:5<996::aid-cncr8>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

Review 1.  Dysplasia east and west.

Authors:  R M Genta
Journal:  Curr Gastroenterol Rep       Date:  2000-12

2.  Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial.

Authors:  Manabu Muto; Keiko Minashi; Tomonori Yano; Yutaka Saito; Ichiro Oda; Satoru Nonaka; Tai Omori; Hitoshi Sugiura; Kenichi Goda; Mitsuru Kaise; Haruhiro Inoue; Hideki Ishikawa; Atsushi Ochiai; Tadakazu Shimoda; Hidenobu Watanabe; Hisao Tajiri; Daizo Saito
Journal:  J Clin Oncol       Date:  2010-02-22       Impact factor: 44.544

3.  Adenocarcinoma of the stomach: a review.

Authors:  James M McLoughlin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

4.  Parameters predicting lymph node metastasis in patients with superficial esophageal squamous cell carcinoma.

Authors:  Liyan Xue; Liqun Ren; Shuangmei Zou; Ling Shan; Xiuyun Liu; Yongqiang Xie; Yueming Zhang; Jun Lu; Dongmei Lin; Sanford M Dawsey; Guiqi Wang; Ning Lu
Journal:  Mod Pathol       Date:  2012-05-25       Impact factor: 7.842

5.  Comparative study of Western and Japanese criteria for biopsy-based diagnosis of gastric epithelial neoplasia.

Authors:  Masao Yoshida; Tadakazu Shimoda; Kimihide Kusafuka; Takashi Sugino; Takashi Nakajima; Hiroyuki Ono
Journal:  Gastric Cancer       Date:  2014-05-01       Impact factor: 7.370

6.  The Vienna classification of gastrointestinal epithelial neoplasia.

Authors:  R J Schlemper; R H Riddell; Y Kato; F Borchard; H S Cooper; S M Dawsey; M F Dixon; C M Fenoglio-Preiser; J F Fléjou; K Geboes; T Hattori; T Hirota; M Itabashi; M Iwafuchi; A Iwashita; Y I Kim; T Kirchner; M Klimpfinger; M Koike; G Y Lauwers; K J Lewin; G Oberhuber; F Offner; A B Price; C A Rubio; M Shimizu; T Shimoda; P Sipponen; E Solcia; M Stolte; H Watanabe; H Yamabe
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

7.  A retrospective study of endoscopic resection for 368 patients with early esophageal squamous cell carcinoma or precancerous lesions.

Authors:  Dongxian Jiang; Xuquan Li; Haixing Wang; Chen Xu; Xiaojing Li; Akesu Sujie; Haiying Zeng; Yingyong Hou; Yunshi Zhong
Journal:  Surg Endosc       Date:  2016-11-11       Impact factor: 4.584

Review 8.  Squamous intraepithelial neoplasia of the esophagus: past, present, and future.

Authors:  Michio Shimizu; Koji Nagata; Hiroshi Yamaguchi; Hiroto Kita
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

9.  Prognostic value and interobserver agreement of endoscopic ultrasonography for superficial squamous cell carcinoma of the esophagus: a prospective study.

Authors:  Hideo Yanai; Toshiya Harada; Takeshi Okamoto; Atsuyoshi Hirano; Naori Takeo; Tomoharu Yoshida; Kiwamu Okita; Toyokazu Kawano
Journal:  Int J Gastrointest Cancer       Date:  2003

10.  A new practical classification of desmoplastic reaction in endoscopic forceps biopsy of colorectal cancer.

Authors:  Haiyan Jing; Liang Shang; Shulei Zhao; Zhigang Yao; Beibei Lv; Xiaolong Zhu
Journal:  Histol Histopathol       Date:  2021-06-15       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.